Reported relationships
Latest disclosed role at each company.
No relationships currently tracked through insider filings.
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
No balances currently tracked through insider filings.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
CVS HEALTH Corp
Report date April 01, 2017 · Filed April 04, 2017
Section 16 reporting ended · disclosed 2017-04-04. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 11,656 |
Ending reported balance
After 2017-04-02 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2017-04-01 · Tax withholding · Disposed 1,129 · Balance 13,252 F1: Surrender of shares in payment of withholding taxes due upon the vesting of a restricted stock unit award. Row 2 · 2017-04-02 · Tax withholding · Disposed 1,596 · Balance 11,656 |
| Common Stock (restricted)SEC Table I · non-derivative | Direct | 16,433 |
Reported balance
After 2017-04-03 transaction · row 3
1 source rowRow 3 · 2017-04-03 · Grant · Acquired 4,804 · Balance 16,433 F2: Consists of restricted stock units awarded pursuant to Issuer's 2010 Incentive Compensation Plan. Restrictions lapse 50% on 4/3/2020 and 50% on 4/3/2022. |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $78.05 · Expires 2024-04-03 | Direct | 37,567 |
Reported balance
After 2017-04-03 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2017-04-03 · Grant · Acquired 37,567 · Balance 37,567 F3: Option becomes exercisable in four equal annual installments, commencing 4/3/2018. |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $36.96 · Expires 2019-09-01 | Direct | 0 |
Reported balance
Holding disclosure · report date 2017-04-01 · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · Balance 0 F4: Option became exercisable in three equal annual installments, commencing 9/1/2012. |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $54.53 · Expires 2020-04-01 | Direct | 11,802 |
Reported balance
Holding disclosure · report date 2017-04-01 · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · Balance 11,802 F5: Option became exercisable in four equal annual installments, commencing 4/1/2014. |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $74.29 · Expires 2021-04-01 | Direct | 29,373 |
Reported balance
Holding disclosure · report date 2017-04-01 · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · Balance 29,373 F6: Option became exercisable in four equal annual installments, commencing 4/1/2015. |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $102.26 · Expires 2022-04-01 | Direct | 23,968 |
Reported balance
Holding disclosure · report date 2017-04-01 · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · Balance 23,968 F7: Option became exercisable in four equal annual installments, commencing 4/1/2016. |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $104.82 · Expires 2023-04-01 | Direct | 23,301 |
Reported balance
Holding disclosure · report date 2017-04-01 · row 10
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 10 · Balance 23,301 F8: Option became exercisable in four equal annual installments, commencing 4/1/2017. |
| Stock UnitSEC Table I · non-derivative | Direct | 10,144.5863 |
Reported balance
Holding disclosure · report date 2017-04-01 · row 4
Holding and transaction disclosures are not merged.
1 source rowRow 4 · Balance 10,144.5863 |
Filing footnotes · ownership attribution and instrument terms
F1: Surrender of shares in payment of withholding taxes due upon the vesting of a restricted stock unit award.
F2: Consists of restricted stock units awarded pursuant to Issuer's 2010 Incentive Compensation Plan. Restrictions lapse 50% on 4/3/2020 and 50% on 4/3/2022.
F3: Option becomes exercisable in four equal annual installments, commencing 4/3/2018.
F4: Option became exercisable in three equal annual installments, commencing 9/1/2012.
F5: Option became exercisable in four equal annual installments, commencing 4/1/2014.
F6: Option became exercisable in four equal annual installments, commencing 4/1/2015.
F7: Option became exercisable in four equal annual installments, commencing 4/1/2016.
F8: Option became exercisable in four equal annual installments, commencing 4/1/2017.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 03, 2017 Filed Apr 4, 2017 21:48 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantStock Option · Derivative | 37,567 | $78.05 Strike: $78.05 | $2,932,104.35 |
DisclosureSEC source: 0001127602-17-014072 · form4.xml · derivative · entry 5 Sussman Andrew · CIK 0001515706 · EVP, Clinical Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,567 Underlying: Common Stock · 37,567 shares Expires 2024-04-03 F3 · derivative.exercise_date: Option becomes exercisable in four equal annual installments, commencing 4/3/2018. Read SEC document |
| April 03, 2017 Filed Apr 4, 2017 21:48 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock (restricted) | 4,804 | $78.05 | $374,952.20 |
DisclosureSEC source: 0001127602-17-014072 · form4.xml · nonDerivative · entry 3 Sussman Andrew · CIK 0001515706 · EVP, Clinical Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,433 F2 · shares: Consists of restricted stock units awarded pursuant to Issuer's 2010 Incentive Compensation Plan. Restrictions lapse 50% on 4/3/2020 and 50% on 4/3/2022. Read SEC document |
| April 02, 2017 Filed Apr 4, 2017 21:48 UTC | CVS HEALTH Corp CVS · Entity 2884 | Tax withholdingCommon Stock | 1,596 | $78.50 | $125,286.00 |
DisclosureSEC source: 0001127602-17-014072 · form4.xml · nonDerivative · entry 2 Sussman Andrew · CIK 0001515706 · EVP, Clinical Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,656 Read SEC document |
| April 01, 2017 Filed Apr 4, 2017 21:48 UTC | CVS HEALTH Corp CVS · Entity 2884 | Tax withholdingCommon Stock | 1,129 | $78.50 | $88,626.50 |
DisclosureSEC source: 0001127602-17-014072 · form4.xml · nonDerivative · entry 1 Sussman Andrew · CIK 0001515706 · EVP, Clinical Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,252 F1 · shares: Surrender of shares in payment of withholding taxes due upon the vesting of a restricted stock unit award. Read SEC document |
| March 13, 2017 Filed Mar 14, 2017 20:21 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionStock Option · Derivative | 6,655 | $0.00 Strike: $45.07 | $0.00 |
DisclosureSEC source: 0001127602-17-011593 · form4.xml · derivative · entry 6 Sussman Andrew · CIK 0001515706 · EVP, Clinical Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,655 shares Expires 2019-04-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Option became exercisable in four equal annual installments, commencing 4/2/2013. Read SEC document |
| March 13, 2017 Filed Mar 14, 2017 20:21 UTC | CVS HEALTH Corp CVS · Entity 2884 | SaleCommon Stock | 7,449 | $80.40 | $598,899.60 |
DisclosureSEC source: 0001127602-17-011593 · form4.xml · nonDerivative · entry 3 Sussman Andrew · CIK 0001515706 · EVP, Clinical Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,697 F1 · kind: All sales were effected pursuant to a Rule 10b5-1 plan. Read SEC document |
| March 13, 2017 Filed Mar 14, 2017 20:21 UTC | CVS HEALTH Corp CVS · Entity 2884 | SaleCommon Stock | 6,655 | $80.40 | $535,062.00 |
DisclosureSEC source: 0001127602-17-011593 · form4.xml · nonDerivative · entry 2 Sussman Andrew · CIK 0001515706 · EVP, Clinical Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,146 F1 · kind: All sales were effected pursuant to a Rule 10b5-1 plan. Read SEC document |
| March 13, 2017 Filed Mar 14, 2017 20:21 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionCommon Stock | 6,655 | $45.07 | $299,940.85 |
DisclosureSEC source: 0001127602-17-011593 · form4.xml · nonDerivative · entry 1 Sussman Andrew · CIK 0001515706 · EVP, Clinical Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,801 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 28, 2017 Filed Mar 2, 2017 21:33 UTC | CVS HEALTH Corp CVS · Entity 2884 | Tax withholdingCommon Stock | 1,912 | $80.58 | $154,068.96 |
DisclosureSEC source: 0001127602-17-009734 · form4.xml · nonDerivative · entry 3 Sussman Andrew · CIK 0001515706 · EVP & Pres, CVS MinuteClinic 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,146 F3 · shares: Surrender of shares in payment of withholding taxes due upon the vesting of a stock award under the Registrant's 2010 Incentive Compensation Plan and Long-Term Incentive Plan. Read SEC document |
| February 28, 2017 Filed Mar 2, 2017 21:33 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantStock Unit | 1,861 | $80.58 | $149,959.38 |
DisclosureSEC source: 0001127602-17-009734 · form4.xml · nonDerivative · entry 2 Sussman Andrew · CIK 0001515706 · EVP & Pres, CVS MinuteClinic 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,144.5863 F2 · shares: Consists of Stock Units awarded at market price pursuant to Issuer's 2010 Incentive Compensation Plan and its Long-Term Incentive Plan, the receipt of which the reporting person has elected to defer. Read SEC document |
| February 28, 2017 Filed Mar 2, 2017 21:33 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock | 5,585 | $80.58 | $450,039.30 |
DisclosureSEC source: 0001127602-17-009734 · form4.xml · nonDerivative · entry 1 Sussman Andrew · CIK 0001515706 · EVP & Pres, CVS MinuteClinic 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,058 F1 · shares: Consists of stock awarded at market price pursuant to Issuer's 2010 Incentive Compensation Plan and its Long-Term Incentive Plan. Read SEC document |
| April 01, 2016 Filed Apr 5, 2016 23:21 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantStock Option · Derivative | 23,301 | $104.82 Strike: $104.82 | $2,442,410.82 |
DisclosureSEC source: 0001127602-16-048902 · form4.xml · derivative · entry 5 Sussman Andrew · CIK 0001515706 · EVP & Pres, CVS MinuteClinic 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,301 Underlying: Common Stock · 23,301 shares Expires 2023-04-01 F4 · derivative.exercise_date: Option becomes exercisable in four equal annual installments, commencing 4/1/2017. Read SEC document |
| April 01, 2016 Filed Apr 5, 2016 23:21 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock (restricted) | 3,100 | $104.82 | $324,942.00 |
DisclosureSEC source: 0001127602-16-048902 · form4.xml · nonDerivative · entry 3 Sussman Andrew · CIK 0001515706 · EVP & Pres, CVS MinuteClinic 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,313 F3 · shares: Consists of restricted stock units awarded pursuant to Issuer's 2010 Incentive Compensation Plan. Restrictions lapse 50% on 4/1/2019 and 50% on 4/1/2021. Read SEC document |
| April 01, 2016 Filed Apr 5, 2016 23:21 UTC | CVS HEALTH Corp CVS · Entity 2884 | Tax withholdingCommon Stock | 1,319 | $104.82 | $138,257.58 |
DisclosureSEC source: 0001127602-16-048902 · form4.xml · nonDerivative · entry 2 Sussman Andrew · CIK 0001515706 · EVP & Pres, CVS MinuteClinic 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,473 F2 · shares: Surrender of shares in payment of withholding taxes due upon the vesting of a restricted stock unit award. Read SEC document |
| April 01, 2016 Filed Apr 5, 2016 23:21 UTC | CVS HEALTH Corp CVS · Entity 2884 | SaleCommon Stock | 2,844 | $105.00 | $298,620.00 |
DisclosureSEC source: 0001127602-16-048902 · form4.xml · nonDerivative · entry 1 Sussman Andrew · CIK 0001515706 · EVP & Pres, CVS MinuteClinic 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,041 F1 · kind: Sales were effected pursuant to a Rule 10b5-1 plan. Read SEC document |
| February 29, 2016 Filed Mar 2, 2016 22:31 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantStock Unit | 1,675 | $97.17 | $162,759.75 |
DisclosureSEC source: 0001127602-16-044572 · form4.xml · nonDerivative · entry 2 Sussman Andrew · CIK 0001515706 · EVP & Pres, CVS/minuteclinic 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,114.8918 F2 · shares: Consists of Stock Units awarded at market price to Issuer's 2010 Incentive Compensation Plan and its Long-Term Incentive Plan, the receipt of which the reporting person has elected to defer. Read SEC document |
| February 29, 2016 Filed Mar 2, 2016 22:31 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock | 5,024 | $97.17 | $488,182.08 |
DisclosureSEC source: 0001127602-16-044572 · form4.xml · nonDerivative · entry 1 Sussman Andrew · CIK 0001515706 · EVP & Pres, CVS/minuteclinic 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,885 F1 · shares: Consists of Stock Units awarded at market price pursuant to Issuer's 2010 Incentive Compensation Plan and its Long-Term Incentive Plan. Read SEC document |
| April 10, 2015 Filed Apr 13, 2015 20:20 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionStock Option · Derivative | 6,655 | $0.00 Strike: $45.07 | $0.00 |
DisclosureSEC source: 0001127602-15-014347 · form4.xml · derivative · entry 9 Sussman Andrew · CIK 0001515706 · EVP & Pres, CVS/minuteclinic 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,655 Underlying: Common Stock · 6,655 shares Expires 2019-04-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: Option became exercisable in four equal annual installments, commencing 4/2/2013. Read SEC document |
| April 10, 2015 Filed Apr 13, 2015 20:20 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionStock Option · Derivative | 5,901 | $0.00 Strike: $54.53 | $0.00 |
DisclosureSEC source: 0001127602-15-014347 · form4.xml · derivative · entry 8 Sussman Andrew · CIK 0001515706 · EVP & Pres, CVS/minuteclinic 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,802 Underlying: Common Stock · 5,901 shares Expires 2020-04-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Option became exercisable in four equal annual installments, commencing 4/1/2014. Read SEC document |
| April 10, 2015 Filed Apr 13, 2015 20:20 UTC | CVS HEALTH Corp CVS · Entity 2884 | SaleCommon Stock | 5,082 | $102.39 | $520,345.98 |
DisclosureSEC source: 0001127602-15-014347 · form4.xml · nonDerivative · entry 5 Sussman Andrew · CIK 0001515706 · EVP & Pres, CVS/minuteclinic 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,861 F1 · kind: All sales were effected pursuant to a Rule 10b5-1 plan. F3 · price: Represents weighted average sale price for this trading day. Multiple sales were executed, with sales prices ranging between $102.11 and $102.70 per share. Read SEC document |
| April 10, 2015 Filed Apr 13, 2015 20:20 UTC | CVS HEALTH Corp CVS · Entity 2884 | SaleCommon Stock | 6,655 | $102.38 | $681,338.90 |
DisclosureSEC source: 0001127602-15-014347 · form4.xml · nonDerivative · entry 4 Sussman Andrew · CIK 0001515706 · EVP & Pres, CVS/minuteclinic 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,943 F1 · kind: All sales were effected pursuant to a Rule 10b5-1 plan. F2 · price: Represents weighted average sale price for this trading day. Multiple sales were executed, with sales prices ranging between $102.06 and $102.72 per share. Read SEC document |
| April 10, 2015 Filed Apr 13, 2015 20:20 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionCommon Stock | 6,655 | $45.07 | $299,940.85 |
DisclosureSEC source: 0001127602-15-014347 · form4.xml · nonDerivative · entry 3 Sussman Andrew · CIK 0001515706 · EVP & Pres, CVS/minuteclinic 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,598 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 10, 2015 Filed Apr 13, 2015 20:20 UTC | CVS HEALTH Corp CVS · Entity 2884 | SaleCommon Stock | 5,901 | $102.38 | $604,144.38 |
DisclosureSEC source: 0001127602-15-014347 · form4.xml · nonDerivative · entry 2 Sussman Andrew · CIK 0001515706 · EVP & Pres, CVS/minuteclinic 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,943 F1 · kind: All sales were effected pursuant to a Rule 10b5-1 plan. F2 · price: Represents weighted average sale price for this trading day. Multiple sales were executed, with sales prices ranging between $102.06 and $102.72 per share. Read SEC document |
| April 10, 2015 Filed Apr 13, 2015 20:20 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionCommon Stock | 5,901 | $54.53 | $321,781.53 |
DisclosureSEC source: 0001127602-15-014347 · form4.xml · nonDerivative · entry 1 Sussman Andrew · CIK 0001515706 · EVP & Pres, CVS/minuteclinic 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,844 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 02, 2015 Filed Apr 3, 2015 20:32 UTC | CVS HEALTH Corp CVS · Entity 2884 | Tax withholdingCommon Stock | 1,596 | $102.71 | $163,925.16 |
DisclosureSEC source: 0001127602-15-013950 · form4.xml · nonDerivative · entry 3 Sussman Andrew · CIK 0001515706 · EVP & Pres, CVS/minuteclinic 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,943 F3 · shares: Surrender of shares in payment of withholding taxes due upon the vesting of a restricted stock award. Read SEC document |
| April 01, 2015 Filed Apr 3, 2015 20:32 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantStock Option · Derivative | 23,968 | $102.26 Strike: $102.26 | $2,450,967.68 |
DisclosureSEC source: 0001127602-15-013950 · form4.xml · derivative · entry 5 Sussman Andrew · CIK 0001515706 · EVP & Pres, CVS/minuteclinic 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,968 Underlying: Common Stock · 23,968 shares Expires 2022-04-01 F4 · derivative.exercise_date: Option becomes exercisable in four equal annual installments, commencing 4/1/2016. Read SEC document |
| April 01, 2015 Filed Apr 3, 2015 20:32 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock (restricted) | 3,422 | $102.26 | $349,933.72 |
DisclosureSEC source: 0001127602-15-013950 · form4.xml · nonDerivative · entry 2 Sussman Andrew · CIK 0001515706 · EVP & Pres, CVS/minuteclinic 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,964 F2 · shares: Consists of Restricted Stock Units awarded pursuant to Issuer's 2010 Incentive Compensation Plan. Restrictions lapse 50% on 4/1/2018 and 50% 4/1/2020. Read SEC document |
| April 01, 2015 Filed Apr 3, 2015 20:32 UTC | CVS HEALTH Corp CVS · Entity 2884 | Tax withholdingCommon Stock | 3,086 | $102.26 | $315,574.36 |
DisclosureSEC source: 0001127602-15-013950 · form4.xml · nonDerivative · entry 1 Sussman Andrew · CIK 0001515706 · EVP & Pres, CVS/minuteclinic 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,211 F1 · shares: Surrender of shares in payment of withholding taxes due upon the vesting of a restricted stock award. Read SEC document |
| February 27, 2015 Filed Mar 3, 2015 22:18 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock | 6,017 | $103.87 | $624,985.79 |
DisclosureSEC source: 0001127602-15-009657 · form4.xml · nonDerivative · entry 1 Sussman Andrew · CIK 0001515706 · SVP & Pres, CVS/minuteclinic 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,861 F1 · shares: Consists of Stock Units awarded at market price pursuant to Issuer's 2010 Incentive Compensation Plan and its Long-Term Incentive Plan. Read SEC document |
| January 02, 2015 Filed Jan 5, 2015 22:00 UTC | CVS HEALTH Corp CVS · Entity 2884 | SaleCommon Stock | 4,220 | $95.67 | $403,712.63 |
DisclosureSEC source: 0001127602-15-000767 · form4.xml · nonDerivative · entry 1 Sussman Andrew · CIK 0001515706 · SVP & Pres, CVS/minuteclinic 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,817.0237 F1 · kind: All sales were effected pursuant to a Rule 10b5-1 plan. F2 · price: Represents weighted average sale price for this trading day. Multiple sales were executed, with sales prices ranging between $94.83 and $96.82 per share. Read SEC document |
| September 02, 2014 Filed Sep 3, 2014 20:43 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionStock Option · Derivative | 9,020 | $0.00 Strike: $36.96 | $0.00 |
DisclosureSEC source: 0001127602-14-027093 · form4.xml · derivative · entry 6 Sussman Andrew · CIK 0001515706 · SVP & President, MinuteClinic 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 9,020 shares Expires 2019-09-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Option became exercisable in three equal annual installments, commencing 9/1/2012. Read SEC document |
| September 02, 2014 Filed Sep 3, 2014 20:43 UTC | CVS HEALTH Corp CVS · Entity 2884 | SaleCommon Stock | 9,020 | $79.45 | $716,639.00 |
DisclosureSEC source: 0001127602-14-027093 · form4.xml · nonDerivative · entry 3 Sussman Andrew · CIK 0001515706 · SVP & President, MinuteClinic 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,037.0237 F2 · kind: All sales were effected pursuant to a Rule 10b5-1 plan. Read SEC document |
| September 02, 2014 Filed Sep 3, 2014 20:43 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionCommon Stock | 9,020 | $36.96 | $333,379.20 |
DisclosureSEC source: 0001127602-14-027093 · form4.xml · nonDerivative · entry 2 Sussman Andrew · CIK 0001515706 · SVP & President, MinuteClinic 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,057.0237 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 01, 2014 Filed Sep 3, 2014 20:43 UTC | CVS HEALTH Corp CVS · Entity 2884 | Tax withholdingCommon Stock | 2,710 | $79.45 | $215,309.50 |
DisclosureSEC source: 0001127602-14-027093 · form4.xml · nonDerivative · entry 1 Sussman Andrew · CIK 0001515706 · SVP & President, MinuteClinic 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,037.0237 F1 · kind: Surrender of shares in payment of withholding taxes due. Read SEC document |
| April 02, 2014 Filed Apr 3, 2014 20:44 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionStock Option · Derivative | 5,901 | $0.00 Strike: $54.53 | $0.00 |
DisclosureSEC source: 0001127602-14-014010 · form4.xml · derivative · entry 10 Sussman Andrew · CIK 0001515706 · SVP & President, MinuteClinic 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,703 Underlying: Common Stock · 5,901 shares Expires 2020-04-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: Option became exercisable in four equal annual installments, commencing 4/1/2014. Read SEC document |
| April 02, 2014 Filed Apr 3, 2014 20:44 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionStock Option · Derivative | 13,309 | $0.00 Strike: $45.07 | $0.00 |
DisclosureSEC source: 0001127602-14-014010 · form4.xml · derivative · entry 9 Sussman Andrew · CIK 0001515706 · SVP & President, MinuteClinic 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,310 Underlying: Common Stock · 13,309 shares Expires 2019-04-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Option became exercisable in four equal annual installments, commencing 4/2/2013. Read SEC document |
| April 02, 2014 Filed Apr 3, 2014 20:44 UTC | CVS HEALTH Corp CVS · Entity 2884 | SaleCommon Stock | 5,901 | $74.02 | $436,819.16 |
DisclosureSEC source: 0001127602-14-014010 · form4.xml · nonDerivative · entry 5 Sussman Andrew · CIK 0001515706 · SVP & President, MinuteClinic 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,829.0681 F2 · kind: All sales were effected pursuant to a Rule 10b5-1 plan. Read SEC document |
| April 02, 2014 Filed Apr 3, 2014 20:44 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionCommon Stock | 5,901 | $54.53 | $321,781.53 |
DisclosureSEC source: 0001127602-14-014010 · form4.xml · nonDerivative · entry 4 Sussman Andrew · CIK 0001515706 · SVP & President, MinuteClinic 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,730.0681 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 02, 2014 Filed Apr 3, 2014 20:44 UTC | CVS HEALTH Corp CVS · Entity 2884 | SaleCommon Stock | 13,309 | $74.02 | $985,193.40 |
DisclosureSEC source: 0001127602-14-014010 · form4.xml · nonDerivative · entry 3 Sussman Andrew · CIK 0001515706 · SVP & President, MinuteClinic 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,829.0681 F2 · kind: All sales were effected pursuant to a Rule 10b5-1 plan. Read SEC document |
| April 02, 2014 Filed Apr 3, 2014 20:44 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionCommon Stock | 13,309 | $45.07 | $599,836.63 |
DisclosureSEC source: 0001127602-14-014010 · form4.xml · nonDerivative · entry 2 Sussman Andrew · CIK 0001515706 · SVP & President, MinuteClinic 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,138.0681 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 01, 2014 Filed Apr 3, 2014 20:44 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantStock Option · Derivative | 29,373 | $74.29 Strike: $74.29 | $2,182,120.17 |
DisclosureSEC source: 0001127602-14-014010 · form4.xml · derivative · entry 8 Sussman Andrew · CIK 0001515706 · SVP & President, MinuteClinic 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,373 Underlying: Common Stock · 29,373 shares Expires 2021-04-01 F3 · derivative.exercise_date: Option becomes exercisable in four equal annual installments, commencing 4/1/2015. Read SEC document |
| April 01, 2014 Filed Apr 3, 2014 20:44 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock (restricted) | 4,711 | $74.29 | $349,980.19 |
DisclosureSEC source: 0001127602-14-014010 · form4.xml · nonDerivative · entry 1 Sussman Andrew · CIK 0001515706 · SVP & President, MinuteClinic 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,306 F1 · shares: Consists of Restricted Stock Units awarded pursuant to Issuer's 2010 Incentive Compensation Plan. Restrictions lapse 50% on 4/1/2017 and 50% on 4/1/2019. Read SEC document |
| February 18, 2014 Filed Feb 20, 2014 21:51 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock | 2,844 | $70.32 | $199,990.08 |
DisclosureSEC source: 0001127602-14-007476 · form4.xml · nonDerivative · entry 1 Sussman Andrew · CIK 0001515706 · SVP & President, MinuteClinic 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,829.0681 F1 · shares: Consists of Stock Units awarded at market price pursuant to Issuer's 2010 Incentive Compensation Plan. Read SEC document |
| September 04, 2013 Filed Sep 5, 2013 20:00 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionStock Option · Derivative | 9,020 | $0.00 Strike: $36.96 | $0.00 |
DisclosureSEC source: 0001127602-13-026693 · form4.xml · derivative · entry 6 Sussman Andrew · CIK 0001515706 · SVP & President, MinuteClinic 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,020 Underlying: Common Stock · 9,020 shares Expires 2019-09-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Option became exercisable in three equal annual installments, commencing 9/1/2012. Read SEC document |
| September 04, 2013 Filed Sep 5, 2013 20:00 UTC | CVS HEALTH Corp CVS · Entity 2884 | SaleCommon Stock | 9,020 | $58.36 | $526,398.18 |
DisclosureSEC source: 0001127602-13-026693 · form4.xml · nonDerivative · entry 2 Sussman Andrew · CIK 0001515706 · SVP & President, MinuteClinic 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,962.8394 F1 · kind: All sales were effected pursuant to a Rule 10b5-1 plan. Read SEC document |
| September 04, 2013 Filed Sep 5, 2013 20:00 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionCommon Stock | 9,020 | $36.96 | $333,379.20 |
DisclosureSEC source: 0001127602-13-026693 · form4.xml · nonDerivative · entry 1 Sussman Andrew · CIK 0001515706 · SVP & President, MinuteClinic 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,982.8394 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 01, 2013 Filed Apr 3, 2013 20:46 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantStock Option · Derivative | 23,604 | $54.53 Strike: $54.53 | $1,287,126.12 |
DisclosureSEC source: 0001127602-13-013292 · form4.xml · derivative · entry 5 Sussman Andrew · CIK 0001515706 · SVP & President, MinuteClinic 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,604 Underlying: Common Stock · 23,604 shares Expires 2020-04-01 F2 · derivative.exercise_date: Option becomes exercisable in four equal annual installments, commencing 4/1/2014. Read SEC document |
| April 01, 2013 Filed Apr 3, 2013 20:46 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock (restricted) | 5,502 | $54.53 | $300,024.06 |
DisclosureSEC source: 0001127602-13-013292 · form4.xml · nonDerivative · entry 1 Sussman Andrew · CIK 0001515706 · SVP & President, MinuteClinic 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,701 F1 · shares: Consists of Restricted Stock Units awarded pursuant to Issuer's 2010 Incentive Compensation Plan. Restrictions lapse 50% on 4/1/2016 and 50% on 4/1/2018. Read SEC document |
| October 04, 2012 Filed Oct 5, 2012 20:09 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionStock Option · Derivative | 9,020 | $0.00 Strike: $36.96 | $0.00 |
DisclosureSEC source: 0001127602-12-028327 · form4.xml · derivative · entry 5 Sussman Andrew · CIK 0001515706 · SVP & President, MinuteClinic 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,040 Underlying: Common Stock · 9,020 shares Expires 2019-09-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Option becomes exercisable in three equal annual installments, commencing 9/1/2012. Read SEC document |
| October 04, 2012 Filed Oct 5, 2012 20:09 UTC | CVS HEALTH Corp CVS · Entity 2884 | SaleCommon Stock | 9,020 | $49.00 | $441,980.00 |
DisclosureSEC source: 0001127602-12-028327 · form4.xml · nonDerivative · entry 2 Sussman Andrew · CIK 0001515706 · SVP & President, MinuteClinic 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,929.1861 F1 · kind: All transactions were effected pursuant to a Rule 10b5-1 plan. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.